Atlas Trials

Cabazitaxel in Relapsed and Metastatic NSCLC

Clinical trial NCT01852578 · COMPLETED

Trial details

NCT number
NCT01852578
Sponsor
Hellenic Oncology Research Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
NSCLC
Start date
2012-09-01
Primary completion
2013-08-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.